PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
04-Sep-2024 Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review Prilenia Therapeutics B.V
04-Sep-2024 GenesisCare UK appoints Second Doctor Director to UK Board GenesisCare UK
04-Sep-2024 Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event CluePoints
04-Sep-2024 Lindus Health Launches "All-in-One Ophthalmology CRO" Tailored to Clinical Trials in Ophthalmology Lindus Health
02-Sep-2024 Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK Theolytics
02-Sep-2024 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform Medigene AG
02-Sep-2024 New Service Center in Veeva Vault CRM Suite Unifies Sales and Service Veeva Systems
29-Aug-2024 European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma Janssen-Cilag International NV,
29-Aug-2024 European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy Janssen-Cilag International NV
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 Leadership Appointments at RQM+ RQM+
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 InsightRX Announces the release of InsightRX GEMINI(SM) InsightRX
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc